In Vitro Diagnostics (IVD) include reagents, instruments, and systems intended for use in the diagnosis of disease or other conditions, including the determination of the state of health, in order to treat or prevent disease. The reagents, instruments and systems are intended for use in the collection, preparation, and examination of specimens taken from the human body. The categories tracked under this market are Cardiac Disease, Hematological Disorders, Hormonal Disorders, Metabolic Disorder, Infectious Disease, IVD Analyzers and Reagents, Oncology and Reproductive Health Diagnostics. Hematology Analyzers consist of analytical laboratory equipment that is used to perform tests related to blood and blood components. GlobalData uses proprietary data and analytics to provide a comprehensive report on the hematology analyzers market in New Zealand. Buy the latest report here.
In 2022, GlobalData’s Market Model methodology determined that the leading player in the hematology analyzers market in New Zealand was Abbott Laboratories followed by Danaher, EKF Diagnostics, Horiba, Nihon Kohden, Shenzhen Mindray Bio-Medical Electronics, Siemens Healthineers and Sysmex.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
Hematology analyzers are also used to identify and determine morphology of blood and blood-forming cells such as white blood cells, lymphocytes, monocytes, neutrophils, eosinophils, and basophils. Hematology analyzers utilize various technological solutions in order to recognize cell types in a blood sample and to count them individually to generate a complete blood count (CBC) with differential. The Hematology analyzers market includes the sub-segments, High-throughput Fixed Hematology Analyzers, Medium-throughput Fixed Hematology Analyzers and Bench Top Point of Care (POC) Hematology Analyzers.
The hematology analyzers market in New Zealand can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size hematology analyzers in New Zealand, buy the report here.